CannaPharmaRx, Inc. (CPMD) stock
CPMDOTCPharmaceutical PreparationsFiscal year ends December 31
$0.00+0.00 (0.00%)
Close on Oct 16, 2026Market cap $2.54MP/E –Yield –
CannaPharmaRx net income
Net income is the profit left for shareholders after every expense, interest and tax.
CannaPharmaRx's net income for the twelve months ending Sep 30, 2026 was -$9.20M. For fiscal 2025 it was -$11.13M. The highest annual figure on record is $3.69M in fiscal 2023.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$11.13M | – |
| FY2024 | Dec 31, 2024 | -$9.91M | -368.6% |
| FY2023 | Dec 31, 2023 | $3.69M | – |
| FY2022 | Dec 31, 2022 | -$8.53M | – |
| FY2021 | Dec 31, 2021 | -$8.83M | – |
| FY2020 | Dec 31, 2020 | -$19.89M | – |
| FY2019 | Dec 31, 2019 | -$20.45M | – |
| FY2018 | Dec 31, 2018 | -$3.09M | – |
| FY2017 | Dec 31, 2017 | -$6.63K | – |
| FY2016 | Dec 31, 2016 | -$1.00M | – |
| FY2015 | Dec 31, 2015 | -$11.74M | – |
| FY2014 | Dec 31, 2014 | -$3.98M | – |
| FY2013 | Dec 31, 2013 | -$94.41K | – |
| FY2012 | Dec 31, 2012 | -$98.07K | – |
| FY2011 | Dec 31, 2011 | -$99.66K | – |
| FY2010 | Dec 31, 2010 | -$99.66K | -191.5% |
| FY2009 | Dec 31, 2009 | $108.86K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $645.42K | – |
| Q2 FY2026 | Jun 30, 2026 | -$1.91M | – |
| Q1 FY2026 | Mar 31, 2026 | -$382.02K | – |
| Q4 FY2025 | Dec 31, 2025 | -$7.55M | – |
| Q3 FY2025 | Sep 30, 2025 | -$1.48M | -884.3% |
| Q2 FY2025 | Jun 30, 2025 | -$1.41M | -126.4% |
| Q1 FY2025 | Mar 31, 2025 | -$690.59K | – |
| Q4 FY2024 | Dec 31, 2024 | -$3.74M | -149.6% |
| Q3 FY2024 | Sep 30, 2024 | $188.42K | – |
| Q2 FY2024 | Jun 30, 2024 | $5.36M | – |
| Q1 FY2024 | Mar 31, 2024 | -$11.72M | – |
| Q4 FY2023 | Dec 31, 2023 | $7.54M | – |
| Q3 FY2023 | Sep 30, 2023 | -$564.37K | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.88M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.64M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.31M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.51M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.07M | -273.0% |
| Q4 FY2021 | Dec 31, 2021 | -$7.34M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.03M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.67M | – |
| Q1 FY2021 | Mar 31, 2021 | $1.20M | – |
| Q4 FY2020 | Dec 31, 2020 | -$11.55M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$1.47M | – |
| Q1 FY2020 | Mar 31, 2020 | -$4.21M | – |
| Q4 FY2019 | Dec 31, 2019 | -$9.31M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.32M | – |
| Q2 FY2019 | Jun 30, 2019 | -$748.08K | – |
| Q1 FY2019 | Mar 31, 2019 | -$1.07M | – |
| Q4 FY2018 | Dec 31, 2018 | -$1.93M | – |
| Q3 FY2018 | Sep 30, 2018 | -$1.09M | – |
| Q2 FY2018 | Jun 30, 2018 | -$70.50K | – |
| Q1 FY2018 | Mar 31, 2018 | $0 | – |
| Q4 FY2017 | Dec 31, 2017 | -$4.97K | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | -$70.50K | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.67K | – |
| Q4 FY2016 | Dec 31, 2016 | -$36.22K | – |
See a number that looks wrong?